Sorrento Appoints Kevin M. Herde As Chief Financial Officer

SAN DIEGO, April 5, 2016 -- (Healthcare Sales & Marketing Network) -- Sorrento Therapeutics, Inc. (SRNE), an antibody-centric, clinical stage biopharmaceutical company developing new treatments for cancer, inflammation and autoimmune diseases, today annou... Biopharmaceuticals, PersonnelSorrento Therapeutics, resiniferatoxin
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news